This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Uwm Research Foundation, Inc., Women & Infants Hospital of Rhode Island. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2018
Title: The Innovative Contributions of Premchendar Nandhikonda
Introduction
Premchendar Nandhikonda is a notable inventor based in Milwaukee, WI. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target the vitamin D receptor. With a total of two patents to his name, Nandhikonda's work is focused on innovative methods for treating cancer and inhibiting angiogenesis.
Latest Patents
Nandhikonda's latest patents include the development of vitamin D receptor-coregulator inhibitors. These patents describe compounds, pharmaceutical compositions, and methods for inhibiting the expression of a vitamin D receptor target gene. They also focus on inhibiting interactions between the vitamin D receptor and at least one vitamin D receptor coactivator, aimed at treating cancer in subjects and inhibiting angiogenesis.
Career Highlights
Throughout his career, Nandhikonda has worked with reputable organizations such as the UWM Research Foundation, Inc. and Women & Infants Hospital of Rhode Island. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Some of Nandhikonda's notable coworkers include Alexander E. Arnold and Preetpal Singh Sidhu. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.
Conclusion
Premchendar Nandhikonda's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his commitment to advancing medical research. His work continues to have a positive impact on cancer treatment and related therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile